Cross-interference of RLR and TLR signaling pathways modulates antibacterial T cell responses
- PMID: 22610141
- DOI: 10.1038/ni.2307
Cross-interference of RLR and TLR signaling pathways modulates antibacterial T cell responses
Abstract
Although the mechanisms by which innate pathogen-recognition receptors enhance adaptive immune responses are increasingly well understood, whether signaling events from distinct classes of receptors affect each other in modulating adaptive immunity remains unclear. We found here that the activation of cytosolic RIG-I-like receptors (RLRs) resulted in the selective suppression of transcription of the gene encoding the p40 subunit of interleukin 12 (Il12b) that was effectively induced by the activation of Toll-like receptors (TLRs). The RLR-activated transcription factor IRF3 bound dominantly, relative to IRF5, to the Il12b promoter, where it interfered with the TLR-induced assembly of a productive transcription-factor complex. The activation of RLRs in mice attenuated TLR-induced responses of the T helper type 1 cell (T(H)1 cell) and interleukin 17-producing helper T cell (T(H)17 cell) subset types and, consequently, viral infection of mice caused death at sublethal doses of bacterial infection. The innate immune receptor cross-interference we describe may have implications for infection-associated clinical episodes.
Comment in
-
Host response: Destructive interference in immunity.Nat Rev Microbiol. 2012 May 28;10(7):441. doi: 10.1038/nrmicro2816. Nat Rev Microbiol. 2012. PMID: 22635165 No abstract available.
-
Innate immunity: Destructive interference of PRRs.Nat Rev Immunol. 2012 Jun 1;12(7):474. doi: 10.1038/nri3245. Nat Rev Immunol. 2012. PMID: 22653229 No abstract available.
-
IRF3: a molecular switch in pathogen responses.Nat Immunol. 2012 Jun 19;13(7):634-5. doi: 10.1038/ni.2346. Nat Immunol. 2012. PMID: 22713822 No abstract available.
Similar articles
-
Regulation of cooperative function of the Il12b enhancer and promoter by the interferon regulatory factors 3 and 5.Biochem Biophys Res Commun. 2013 Jan 4;430(1):95-100. doi: 10.1016/j.bbrc.2012.11.006. Epub 2012 Nov 12. Biochem Biophys Res Commun. 2013. PMID: 23154183
-
TLR and RLR Signaling Are Reprogrammed in Opposite Directions after Detection of Viral Infection.J Immunol. 2015 Nov 1;195(9):4387-95. doi: 10.4049/jimmunol.1500079. Epub 2015 Sep 21. J Immunol. 2015. PMID: 26392465
-
Negative regulation of TLR-signaling pathways by activating transcription factor-3.J Immunol. 2007 Sep 15;179(6):3622-30. doi: 10.4049/jimmunol.179.6.3622. J Immunol. 2007. PMID: 17785797
-
Targeting Syk-Card9-activating C-type lectin receptors by vaccine adjuvants: findings, implications and open questions.Immunobiology. 2011 Nov;216(11):1184-91. doi: 10.1016/j.imbio.2011.06.005. Epub 2011 Jun 21. Immunobiology. 2011. PMID: 21742403 Review.
-
Innate and intrinsic antiviral immunity in skin.J Dermatol Sci. 2014 Sep;75(3):159-66. doi: 10.1016/j.jdermsci.2014.05.004. Epub 2014 Jun 2. J Dermatol Sci. 2014. PMID: 24928148 Review.
Cited by
-
Clinical significance of TLR3 and TLR4 in peripheral blood mononuclear cells from children with Henoch-Schönlein purpura nephritis.Exp Ther Med. 2014 Jun;7(6):1703-1707. doi: 10.3892/etm.2014.1638. Epub 2014 Mar 27. Exp Ther Med. 2014. PMID: 24926370 Free PMC article.
-
Self-regulation and cross-regulation of pattern-recognition receptor signalling in health and disease.Nat Rev Immunol. 2016 Jan;16(1):35-50. doi: 10.1038/nri.2015.8. Nat Rev Immunol. 2016. PMID: 26711677 Review.
-
Taking the STING out of TLR-driven autoimmune diseases: good, bad, or indifferent?J Leukoc Biol. 2017 Jan;101(1):121-126. doi: 10.1189/jlb.3MR0316-115R. Epub 2016 Aug 16. J Leukoc Biol. 2017. PMID: 27531928 Free PMC article. Review.
-
NOD1/2 and the C-Type Lectin Receptors Dectin-1 and Mincle Synergistically Enhance Proinflammatory Reactions Both In Vitro and In Vivo.J Inflamm Res. 2020 Jul 22;13:357-368. doi: 10.2147/JIR.S245638. eCollection 2020. J Inflamm Res. 2020. PMID: 32801829 Free PMC article.
-
Epidemiologic and molecular pathophysiology of chronic opioid dependence and the place of naltrexone extended-release formulations in its clinical management.Subst Abuse. 2012;6:115-33. doi: 10.4137/SART.S9031. Epub 2012 Sep 27. Subst Abuse. 2012. PMID: 23055738 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases